Mayo LD - Search Results

1

A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.

Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, Donner DB. Ozes ON, et al. Among authors: mayo ld. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4640-5. doi: 10.1073/pnas.051042298. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287630 Free PMC article.

2

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.

Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. Ozes ON, et al. Among authors: mayo ld. Nature. 1999 Sep 2;401(6748):82-5. doi: 10.1038/43466. Nature. 1999. PMID: 10485710

3

Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.

Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB. Wu LW, et al. Among authors: mayo ld. J Biol Chem. 2000 Feb 18;275(7):5096-103. doi: 10.1074/jbc.275.7.5096. J Biol Chem. 2000. PMID: 10671553 Free article.

4

VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor.

Wu LW, Mayo LD, Dunbar JD, Kessler KM, Ozes ON, Warren RS, Donner DB. Wu LW, et al. Among authors: mayo ld. J Biol Chem. 2000 Mar 3;275(9):6059-62. doi: 10.1074/jbc.275.9.6059. J Biol Chem. 2000. PMID: 10692392 Free article.

5

Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation.

Guo DQ, Wu LW, Dunbar JD, Ozes ON, Mayo LD, Kessler KM, Gustin JA, Baerwald MR, Jaffe EA, Warren RS, Donner DB. Guo DQ, et al. Among authors: mayo ld. J Biol Chem. 2000 Apr 14;275(15):11216-21. doi: 10.1074/jbc.275.15.11216. J Biol Chem. 2000. PMID: 10753929 Free article.

6

Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase.

Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB. Mayo LD, et al. J Biol Chem. 2001 Jul 6;276(27):25184-9. doi: 10.1074/jbc.M102932200. Epub 2001 May 2. J Biol Chem. 2001. PMID: 11335727 Free article.

7

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Mayo LD, Donner DB. Mayo LD, et al. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11598-603. doi: 10.1073/pnas.181181198. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504915 Free PMC article.

8

PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.

Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. Mayo LD, et al. J Biol Chem. 2002 Feb 15;277(7):5484-9. doi: 10.1074/jbc.M108302200. Epub 2001 Nov 29. J Biol Chem. 2002. PMID: 11729185 Free article.

9

The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.

Mayo LD, Donner DB. Mayo LD, et al. Trends Biochem Sci. 2002 Sep;27(9):462-7. doi: 10.1016/s0968-0004(02)02166-7. Trends Biochem Sci. 2002. PMID: 12217521 Review.

10

PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.

Su JD, Mayo LD, Donner DB, Durden DL. Su JD, et al. Among authors: mayo ld. Cancer Res. 2003 Jul 1;63(13):3585-92. Cancer Res. 2003. PMID: 12839945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters